We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Form 483 Accuses Glenmark of Lapses in Controls and Storage
Form 483 Accuses Glenmark of Lapses in Controls and Storage
A newly released Form 483 faults Indian drugmaker Glenmark Pharmaceuticals for neglecting multiple controls in its procedures at its Pithampur facility.